1Busso N, Hamilton JA. Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis [ J ]. Arthritis Rheum, 2002,46 (9) : 2268-2279.
3Arnett FC,Edworthy SM,Bloch DA,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis [J]. Arthritis Rheum, 1988, 31(3) :315-324.
4Prevoo ML, van't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis [J]. Arthritis Rheum, 1995,38( 1 ) :44-48.
3Gabriel SE. The epidemiology of rheumatoid arthritis [J]. Rheum Dis Clin North Am, 2001, 27 (2): 269-281.
4蒋明,朱立平,林孝义.风湿病学(上册)[M].北京:科学出版社,1998:365-377.
5Vaughan JH. Pathogenetic concepts and origins of rheumatoid factor in rheumatoid arthritis [ J ]. Arthritis Rheum, 1993,36 ( 1 ) : 1-6.
6Van Schaardenburg D, Hazes JM, de Boer A, et al. Outcome of rheumatoid arthritis in relation to age and rheumatoid factor at diagnosis [ J ]. J Rheumatol, 1993,20( 1 ) :45-52.
7Bizzaro N, Mazzanti G, Tonutti E, et al. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis [ J ]. Clin Chem, 2001,47 ( 6 ) : 1089- 1093.
8Schellekens GA, Visser H, de Jong BA, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide [ J]. Arthritis Rheum, 2000 ,43 ( 1 ) : 155-163.
9Cader MZ,Filer AD,Bucldey CD,et al. The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis [ J ]. BMC Musculoskelet Disord,2010,11 (1) :187.
10Caro-Oleas JL, Fernandez-Suarez A, Reneses Cesteros S, et al. Evaluation of third generation anti-CCP antibodies in the diagnosis of rheumatoid arthritis from undifferentiated polyarthritis after 4 years of follow-up [ J ]. Clin Exp Rheumatol, 2008, 26 ( 3 ) : 461-463.
4Chen L,Lu Y,Chu Y,et al.Tissue factor expression in rheumatoid synovium:A potential role in pannus invasion of rheumatoid arthritis[J].Acta Histochem,2013,115(7):692-697.
5Hernández-Molina G,Avila-Casado C,Nuez-Alvarez C,et al.Utility of the American-European Consensus Group and American College of Rheumatology Classification Criteria for Sjgren's syndrome in patients with systemic autoimmune diseases in the clinical setting[J].Rheumatology(Oxford),2015,54(3):441-448.
6Sengul I,Akcay-Yalbuzdag S,Ince B,et al.Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis[J].Int J Rheum Dis,2015,10(7):89-92.
7Pretorius E,Oberholzer HM,van der Spuy WJ,et al.Scanning electron microscopy of fibrin networks in rheumatoid arthritis:a qualitative analysis[J].Rheumatol Int,2012,32(6):1611-1615.
8Chu Y,Wang F,Zhou M,et al.A preliminary study on the characterization of follicular helper T(Tfh)cells in rheumatoid arthritis synovium[J].Acta Histochem,2014,116(3):539-543.
9Dimitroulas T,Douglas KM,Panoulas VF,et al.Derangement of hemostasis in rheumatoid arthritis:association with demographic,inflammatory and metabolic factors[J].Clin Rheumatol,2013,32(9):1357-1364.
10Kang JH,Keller Julian YK,et al.A population-based case-control study on the association between rheumatoid arthritis and deep vein thrombosis[J].J Vasc Surg,2012,56(6):1642-1648.
